Appel, Gerald B.
Article History
First Online: 16 November 2015
Competing interests
: G.B.A. has received research grants from Bristol–Myers Squibb, Genentech and Regulus. He lectures for Genentech and Takeda and he is a consultant for Alexion, Amgen, Boerhinger Ingelheim, Bristol–Myers Squibb, EMD Serono, Genentech, Genzyme–Sanofi, Mallinkrodt, Merck, Novartis, Pfizer, Regulus, Roche, Takeda, Teva and Up-to-Date. He has no major stock holdings or ownerships.